TET1 exerts its anti-tumor functions via demethylating DACT2 and SFRP2 to antagonize Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma cells. This evidence concerns the gene SFRP2 and nasopharyngeal carcinoma.